Category Archives: Blog

Time to Cut the Cord: Why Animal-Based ECMs Have No Place in the Future of 3D Cell Models

In April 2025, the U.S. Food and Drug Administration (FDA) announced a groundbreaking initiative to phase out the animal testing requirement for monoclonal antibodies and other drugs. This marked a significant milestone in the advancement of preclinical research. Experts from regulatory agencies, academia, and industry worldwide convened to promote the adoption of New Approach Methodologies […]